insights_auto
Outlook: 72.4% bullish·0.0% bearish
Go to analysischevron_right
ABBV:NYSE
AbbVie Common Stock
$282.68
arrow_downward
-0.96%(-2.74) 1D
$282.60
arrow_downward
-0.03% (-0.080)bedtimeAfter hours
Closed: Oct 19, 4:03:54 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ABBV...
Open
$284.23
High
$287.93
Low
$282.59
Mkt. cap
499.53B
Avg. vol.
4.82M
Volume
4.17M
Dividend
2.45%
Quarterly dividend
$1.73
Ex-dividend date
Oct 15, 2026
P/E ratio
79.95
52-wk high
$291.40
52-wk low
$190.75
EPS
$3.54
Beta
0.23
Shares outstanding
1.77B
No. of employees
57K
Open
$284.23
High
$287.93
Low
$282.59
Mkt. cap
499.53B
Avg. vol.
4.82M
Volume
4.17M
Dividend
2.45%
Quarterly dividend
$1.73
Ex-dividend date
Oct 15, 2026
P/E ratio
79.95
52-wk high
$291.40
52-wk low
$190.75
EPS
$3.54
Beta
0.23
Shares outstanding
1.77B
No. of employees
57K
News stories
From web sources and news partners
Simply Wall Street
·
4 hours ago
AbbVie (ABBV) Posts Fresh Trial Wins, Is The Stock Fully Valued?
Kalkine Media
·
6 hours ago
AbbVie (NYSE:ABBV) Draws Attention as Next-Generation Drugs Scale
The Globe and Mail
·
7 hours ago
2 High-Flying Dividend Stocks to Buy and Hold for a Decade
Yahoo Finance
·
10 hours ago
AbbVie (ABBV) Unveils Phase 2a Crohn's Data And Flags 2026 ESMO Readouts
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Websiteabbvie.com